Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

New COX-2-selective compounds in development at Merck Frosst

April 9, 1998

Aspartame has potent antiarthritic activity in preclinical models and arthritic subjects

April 8, 1998

Celtrix reports interim results of phase II clinical study of SomatoKine

April 8, 1998

HMR files for European, American approval of arthritis drug

April 7, 1998

Inhibitors of MMP enzymes synthesized at American Cyanamid

April 7, 1998

Immunex and ArQule form alliance to discover new antiinflammatory drug candidates

April 3, 1998

MGI now distributing Salagen for Sjogren's syndrome in U.S.

April 2, 1998

Celecoxib copromotion agreement expanded

March 26, 1998

First report of nonpeptide compounds as MHC class II inhibitors

March 26, 1998

Further mechanism-of-action studies conducted on T-614

March 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...